Press Releases

  • Certara Appoints Nathan Teuscher to Lead Phoenix Software Division

    PRINCETON, NJ - Jul 21, 2016 - Certara®, the leading provider of decision support technology and consulting services for optimizing drug development and improving health outcomes, today announced the appointment of Nathan Teuscher, PhD, to vice president of pharmacometric solutions

    Jul 21, 2016
  • Non-profit Research Accelerator Curable to Host its 2016 GAME CHANGER Gala and Mike Ditka Day in Pittsburgh on July 30

    PITTSBURGH, PA - Jul 21, 2016 - Curable, a non-profit research accelerator that applies engineering approaches to medicine, today announced that its annual GAME CHANGER Gala will be held from 5:30-10 p

    Jul 21, 2016
  • Mitsubishi Tanabe Joins Certara’s Simcyp Consortium

    PRINCETON, NJ - Jul 20, 2016 - Certara®, the leading provider of decision support technology and consulting services for optimizing drug development and improving health outcomes, today announced that Mitsubishi Tanabe has joined its Simcyp Consortium and licensed its proprietary Simcyp® Population-based Simulator

    Jul 20, 2016
  • Indivumed and Definiens Partner to Unlock the Power of Tumor Tissue for Drug Discovery and Development

    MUNICH, GERMANY - Jul 19, 2016 - Definiens, the pioneer in Tissue Phenomics solutions for diagnostics development and commercialization and Indivumed, GmbH, based in Hamburg, Germany announced today a strategic partnership to offer a unique combination of tissue-based biomarker validation and assay development with Definiens Cognition Network Technology® for image analysis and data mining

    Jul 19, 2016
  • Non-profit Research Accelerator SAVE JON Relaunches as Curable

    PITTSBURGH, PA - Jul 6, 2016 - SAVE JON, a non-profit research accelerator that applies engineering approaches to medicine, today announced that it is relaunching as Curable

    Jul 6, 2016
  • Industry’s Largest TMF Survey Finds Major Change Underway in Clinical Operations

    PHILADELPHIA, PA, UNITED STATES - Jun 28, 2016 - Today, at the Drug Information Association’s (DIA) Annual Meeting, Veeva Systems (NYSE:VEEV) reported the latest findings of the industry’s largest, annual global survey of trial master file (TMF) owners, the Veeva 2016 Paperless TMF Survey

    Jun 28, 2016
  • Bioclinica eHealth Solutions Platform Integrates with Clinical Reach by Parallel 6,

    DOYLESTOWN, PA - Jun 27, 2016 - Bioclinica®, a specialty clinical trials technology and services provider, today announced Parallel 6 has become the newest member of its eHealth App xChange™, an alliance channel within the eHealth Solutions business segment to advance technology innovation across life sciences and healthcare

    Jun 27, 2016
  • Bioclinica eHealth Solutions Launches Safety and Regulatory Software Products

    DOYLESTOWN, PA, USA - Jun 22, 2016 - Bioclinica®, a specialty clinical trials technology and services provider, today announced the expansion of its extensive Safety & Regulatory Solutions portfolio by introducing three new software products to manage every stage in the pharmacovigilance process

    Jun 23, 2016
  • Certara Introduces the D360 Express Data Platform for Biotech R&D

    PRINCETON, NJ - Jun 23, 2016 - Certara®, the leading provider of decision support technology and consulting services for optimizing drug development and improving health outcomes, today announced the availability of D360 Express

    Jun 23, 2016
  • ERT’s Insights Cloud™ Brings Simplicity to Complex Relationships between Sponsors and CROs

    PHILADELPHIA, PA, UNITED STATES - Jun 23, 2016 - ERT, a leading eClinical solutions provider, including high-quality patient data collection and analysis, today announced a major release of its Insights Cloud trial oversight solution, with features to optimize transparency, flexibility and accountability for clinical trial sponsors and Clinical Research Organization (CROs)

    Jun 22, 2016
  • CenterWatch Joins WIRB-Copernicus Group

    PRINCETON, NJ - Jun 22, 2016 - WIRB-Copernicus Group® (WCG™), one of the world's leading providers of solutions that measurably improve the quality and efficiency of clinical research, today announced its acquisition of CenterWatch, the leading provider of clinical trial industry news and information, and the addition of Kenneth A

    Jun 22, 2016
  • ERT Develops Industry’s First Integration of Continuous Glucose Monitoring Data and eCOA

    PHILADELPHIA, PA, UNITED STATES - Jun 22, 2016 - ERT, a leading provider of high-quality patient data collection solutions for use in clinical drug development, today announced a data license agreement with Dexcom to integrate glucose information captured via continuous glucose monitoring (CGM) and traditional self-monitoring of blood glucose (SMBG) with symptomatic / quality of life data collected via its its electronic Clinical Outcome Assessment (eCOA) system

    Jun 21, 2016
  • Rho Recognized for Exemplary Workplace Practice

    Receives prestigious When Work Works Award for the fourth time   Chapel Hill, NC (June 15, 2016) – Rho, a full service contract research organization (CRO) focused on bringing new products to market

    Jun 20, 2016
  • Definiens to Present at First Rational Combinations 360° Conference in New York

    MUNICH, GERMANY - Jun 20, 2016 - Definiens, the pioneer in Tissue Phenomics solutions for diagnostics development and commercialization, today announced that chief commercial officer Merrilyn Datta, PhD, will present at Rational Combinations 360°, being held in New York, NY from June 23-24, 2016

    Jun 20, 2016
  • Bioclinica debuts two divisions focused on patient engagement

    DOYLESTOWN, PA - Jun 15, 2016 - Bioclinica®, a specialty clinical trials technology and services provider, today announced the debut of two new divisions, creating an integrated offering focused on patient engagement

    Jun 15, 2016
  • ERT Brings Innovative Patient Data Collection Concepts to Clinical Researchers

    PHILADELPHIA, PA, UNITED STATES - Jun 16, 2016 - ERT, a leading provider of high-quality patient data collection solutions for use in clinical drug development, today announced that its’ Innovation Lab will travel to the Drug Information Association (DIA) Annual Meeting to give clinical researchers access to advanced models for clinical trials and patient data collection

    Jun 15, 2016
  • WIRB-Copernicus Group Acquires Data and Technology from karmadata

    PRINCETON, NJ - Jun 15, 2016 - WIRB-Copernicus Group® (WCG™), one of the world's leading providers of solutions that measurably improve the quality and efficiency of clinical research, today announced an industry-transforming agreement with karmadata, the market leader in clinical trial database and decision support applications

    Jun 15, 2016
  • ERT Introduces Centralized DLCO Services for Respiratory Trials

    PHILADELPHIA, PA, UNITED STATES - Jun 15, 2016 - ERTIntroduces Centralized DLCO Services for Respiratory TrialsCentralization reduces data variability, improves trial efficiencies ERT, a leading provider of high-quality patient data collection solutions for use in clinical drug development, today introduced its  Centralized Services  for assessing diffusing capacity of the lungs for carbon monoxide (DLCO) data in respiratory clinical trials

    Jun 15, 2016
  • Rho to Recruit New Team Members for 30 Open Positions During DIA 2016 Annual Meeting

    CHAPEL HILL, NC, UNITED STATES - Jun 8, 2016 - WHAT:  Rho, a full-service contract research organization (CRO), is making the most of its presence at one of the industry's leading events by seeking out talent to fill a number of clinical research positions during the Drug Information Association (DIA) 2016 Annual Meeting, the largest global interdisciplinary event for disciplines involved in the discovery, development and life cycle management of health care products

    Jun 8, 2016
  • Certara and the FDA Extend Their Partnership to Develop PBPK Models to Support Veterinary Drug Evaluations

    PRINCETON, NJ - Jun 8, 2016 - Certara®, the global biosimulation technology-enabled drug development company, today announced that the US Food and Drug Administration’s (FDA’s) Center for Veterinary Medicine has extended its five-year Cooperative Research and Development Agreement (CRADA) with the company until 2020

    Jun 8, 2016